Yvette Lux, NP
Acute Care · Kansas City, MONPI 1679946222
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 15.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $729, 2.2 times the $332 reported in 2022.
Across 36 payments — averaging $43.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$245
- AbbVie$170
- Amgen$167
- E.r. Squibb & Sons, L.L.C.$136
- GSK$132
- Antares Pharma, Inc.$113
- plus $614 from 15 others
What the payments were for
- Food & beverage$1,577100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 3 | $245 |
| AbbVie | 8 | $170 |
| Amgen | 3 | $167 |
| E.r. Squibb & Sons, L.L.C. | 1 | $136 |
| GSK | 2 | $132 |
| Antares Pharma, Inc. | 1 | $113 |
| Sanofi | 1 | $107 |
| Convatec Inc. | 1 | $106 |
| Otsuka America Pharmaceutical, Inc. | 1 | $103 |
| AstraZeneca | 2 | $47 |
| Exact Sciences | 2 | $43 |
| Sanofi-aventis U.S. LLC | 1 | $36 |
| Merck | 2 | $30 |
| Idorsia Pharmaceuticals US Inc | 1 | $25 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Collegium Pharmaceutical, Inc. | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $18 |
| Noven Therapeutics, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Ironshore Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,577 in reported general payments places this provider in the 80th percentile of 272 acute care providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other acute care in Kansas City
- Molly CahillKansas City$22K
- Sarah HeaveyKansas City$9K
- Caroline MundhenkeKansas City$6K
- Lisa JenningsKansas City$4K
- Jennifer BranchKansas City$3K
- Gwendolyn GivensKansas City$2K
- Kristin PressChesterfield$14K
- Nedra HarringtonPotosi$8K
- Hunter SmithColumbia$7K
- Heather UelhofO Fallon$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.